Migraine. Migraine
Conditions
Interventions
Intervention 1: Control group:In this group, there are 42 patients with migraine who use topiramate at a dose of 50 mg made by Sobhan Iranian Pharmaceutical Company. This drug is used daily for two mo
Sponsors
Esfahan University of Medical Sciences
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Patient satisfaction Having a migraine criterion based on the International Headache Association criteria
Exclusion criteria
Exclusion criteria: History of addiction to any drug Treated with herbal medicines and other palliative medicine treatments Treated with other prophylactic drugs Treated with corticosteroids
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Quality of life. Timepoint: Before and two months after the start of the intervention. Method of measurement: Headache Impact Test: HIT.;Mental Health. Timepoint: Before and two months after the start of the intervention. Method of measurement: Patient Health Question questionnaire: PHQ.;Severity of headache. Timepoint: Before and two months after the start of the intervention. Method of measurement: Visual Analogue Scale.;Duration of headache per attack. Timepoint: Before and two months after the start of the intervention. Method of measurement: Question from the patient.;Number of headaches per week. Timepoint: Before and two months after the start of the intervention. Method of measurement: Question from the patient. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactFariborz Khorvash
Esfahan University of Medical Sciences
Outcome results
None listed